ARCHIVES

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

Low-Income Women Lack Mammography Access: Survey

May 14, 1993

Fisher Seeks Damages Under Privacy Act; NIH Consents To Remove Database Flags

March 10, 1995

Stand Up To Cancer Says $80 Million in Pledges Raised

September 17, 2010

NAS To Honor Outstanding Scientists

February 28, 1997

Funding Mechanisms: How They Are Used

August 12, 1983

FDA Should Delay Provenge Decision Pending Definitive Trial Results, ODAC Chairman Writes.

April 27, 2007